DFine's STAR Spinal Tumor Ablation System To Hit U.S. Market In Q4
This article was originally published in The Gray Sheet
DFine plans to begin a gradual commercial launch late this year of its STAR system, designed to help cancer patients suffering from painful metastases in the spine.
You may also be interested in...
The latest product approvals and launches.
AF ablation: intracranial impact?
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.